Mapping the EORTC QLQ-C30 onto EQ-5D-5L utility among chronic myeloid leukemia patients
Tạp chí Nghiên cứu Dược và Thông tin Thuốc · 25.04.2026 · 29
DOI: 10.59882/1859-364x/382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tạp chí Nghiên cứu Dược và Thông tin Thuốc, online erschienen am 25.04.2026. Verfasst von Nguyen Thi Thu Cuc und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The quality of life data is often obtained from the non-preference-based instruments with high accuracy and good performance in reflecting changes in the health state. However, these instruments could not generate utility values for the health economic assessments. This study aims to develop and compare the predictive performance of some mapping algorithms from EORTC QLQ-C30 onto the EQ-5D-5L index among chronic myeloid leukemia (CML) patients. A multicenter survey was done via face-to-face interviews (n=494). Four mapping models with independent variables (QLQ-C30 subscales/items, the interaction terms, and demographic and clinical characteristics of patients) were explored via the Bayesian Model Averaging approach. Six regression methods were used to develop the mapping algorithms (Ordinary least squares (OLS), Censored and least absolute deviations, Beta model, Adjusted limited dependent variable model, Linear two-part, and Beta two-part model. The root mean square (RMSE), mean absolute error (MAE), Pearson correlation (r), and Intraclass correlation (ICC) were calculated based on five-fold cross-validation and full population to assess the predictive performance and compare the goodness-of-fit of algorithms. The OLS model 4, including nine QLQ-C30 statistically significant items, two interaction terms, and four demographic and clinical variables, was the best-fit model based on RMSE (0.0769), MAE (0.0578), r (0.7283), and ICC (0.8191) based on the full population. The mapping algorithm converting QLQ-C30 onto EQ-5D-5L value had good predictive validity. The model had many applications in exploring utility in health economic assessments among chronic myeloid leukemia and other cancers.
Zitieren
APA
Cuc, N. T. T., Huong, V. T., & Tuan, D. V. (2026). Mapping the EORTC QLQ-C30 onto EQ-5D-5L utility among chronic myeloid leukemia patients. Tạp chí Nghiên cứu Dược và Thông tin Thuốc, 29. https://doi.org/10.59882/1859-364x/382
Vancouver
Cuc NTT, Huong VT, Tuan DV. Mapping the EORTC QLQ-C30 onto EQ-5D-5L utility among chronic myeloid leukemia patients. Tạp chí Nghiên cứu Dược và Thông tin Thuốc. 2026;29. doi:10.59882/1859-364x/382
BibTeX
@article{Cuc2026,
author = {Cuc, Nguyen Thi Thu and Huong, Vuong Thi and Tuan, Duong Viet},
title = {Mapping the EORTC QLQ-C30 onto EQ-5D-5L utility among chronic myeloid leukemia patients},
journal = {Tạp chí Nghiên cứu Dược và Thông tin Thuốc},
year = {2026},
volume = {29},
doi = {10.59882/1859-364x/382}
}
EUVIMED